Patent details

EP3423082 Title: LIRAGLUTIDE IN CARDIOVASCULAR CONDITIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3423082
WO Application Number:
EP2017054990
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17710160.7
WO Publication Number:
WO2017149112
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Denmark (DK)
Publications:

Dates

Filing date:
03/03/2017
Grant date:
04/08/2021
EP Publication Date:
09/01/2019
WO Publication Date:
08/09/2017
Claims Translations Received Date:
Claims Translation B1 Received Date:
08/10/2021
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/08/2021
EP B1 Publication Date:
04/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
02/03/2037
Lapsed By Expiration Date:
Patent Validated Date:
27/10/2021
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
04/08/2021
 
 

 

Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 BAGSVÆRD, Denmark (DK)

Agent

Name:
dr. W.A.H.M. Van Borm
From:
26/10/2021
Address:
DIPS Belgium bv Kernenergiestraat 19 bus P4, B-2610, Antwerpen (Wilrijk), Belgium (BE)
To:

Inventor

1

Name:
RASMUSSEN, Søren
Address:
2880 Bagsværd, Denmark (DK)

2

Name:
KVIST, Kajsa
Address:
2880 Bagsværd, Denmark (DK)

Priority

1

Priority Patent Number:
201715401651
Priority Date:
09/01/2017
Priority Country:
United States of America (US)

2

Priority Patent Number:
16001329
Priority Date:
13/06/2016
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Patent Number:
16173917
Priority Date:
10/06/2016
Priority Country:
European Patent Office (EPO) (EP)

4

Priority Patent Number:
16158739
Priority Date:
04/03/2016
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 38/26; A61K 47/02; A61P 3/10; A61P 7/12; A61P 9/00; A61P 9/04; A61P 9/10; A61P 13/12; A61P 43/00; A61K 47/10;

Publication

Bulletin

1

Bulletin Heading:
VB1
Journal edition number:
23/22
Publication date:
08/06/2022
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

2

Bulletin Heading:
EP3
Journal edition number:
43/21
Publication date:
27/10/2021
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
31/21
Publication date:
04/08/2021
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202223
Publication date:
08/06/2022
Description:
Opposition procedure started

2

Issue number:
202131
Publication date:
04/08/2021
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
10
Annual Fee Amount:
400 Euro
Last Annual Payment Date:
19/02/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
340 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
26/10/2021 Outgoing Correspondence Letter no formal defects 1 PDF /0/8/9/9/0/0800709980/docs/ep17710160.7_1_442283l271.pdf
08/10/2021 Claims First filed claims 2 PDF /0/8/9/9/0/0800709980/docs/ep17710160.7_0_claims20211008124547333.pdf